sameAs
Paracetamol pack size restriction: the impact on paracetamol poisoning and the over-the-counter supply of paracetamol, aspirin and ibuprofenSurveillance of methadone-related poisonings in Kentucky using multiple data sourcesEvaluation of body mass index, pre-vaccination serum progesterone levels and anti-anthrax protective antigen immunoglobulin G on injection site adverse events following anthrax vaccination in womenGinkgo biloba and risk of cancer: secondary analysis of the Ginkgo Evaluation of Memory (GEM) StudyIncreasing off-label use of antipsychotic medications in the United States, 1995-2008The impact of medicinal drugs on traffic safety: a systematic review of epidemiological studiesAdvantages and problems with pregnancy registries: observations and surprises throughout the life of the International Lamotrigine Pregnancy RegistryMeasuring frailty using claims data for pharmacoepidemiologic studies of mortality in older adults: evidence and recommendationsDisease risk score as a confounder summary method: systematic review and recommendationsA systematic review of validated methods for identifying heart failure using administrative dataA systematic review of validated methods for identifying atrial fibrillation using administrative dataAdherence to oral diabetes medications and glycemic control during and following breast cancer treatment.Near real-time vaccine safety surveillance using electronic health records-a systematic review of the application of statistical methodsPharmacoepidemiological safety studies in children: a systematic reviewA case-control study of acetaminophen use in relation to the risk of first myocardial infarction in menRisk factors for adverse events in analgesic drug users: results from the PAIN studyPattern of drug utilization among hypertensives in a Nigerian teaching hospitalRegional variation in the prescribing for diabetes and use of secondary preventative therapies in IrelandPotential limitations of electronic database studies of prescription non-aspirin non-steroidal anti-inflammatory drugs (NANSAIDs) and risk of myocardial infarction (MI)Ulcer complications associated with anti-inflammatory drug use. What is the extent of the disease burden?The importance of validating the diagnosis of coronary heart disease when measuring secondary prevention: a cross-sectional study in general practiceTreatment with statins after acute myocardial infarction in patients >or=80 years: underuse despite general acceptance of drug therapy for secondary preventionThe effect of admission to a geriatric ward on medication use: 2002 versus 1985The nature and frequency of potential warfarin drug interactions that increase the risk of bleeding in patients with atrial fibrillationFrequency of use of acetaminophen, nonsteroidal anti-inflammatory drugs, and aspirin in US womenUtilization review of concomitant use of potentially interacting drugs in Thai patients using warfarin therapyValidation studies of the health improvement network (THIN) database for pharmacoepidemiology researchParabolas of medication use and discontinuation after myocardial infarction--are we closing the treatment gap?Antipyretic drug use in children in French office based medical practiceUtilisation review of clopidogrel: are they used under the FDA-approved indications?The impact of pharmaceuticals on the decline of cardiovascular mortality in GermanyDrug-induced upper gastrointestinal disorders requiring hospitalization: a five-year study in a South Indian hospitalFrequent monthly use of selected non-prescription and prescription non-narcotic analgesics among U.S. adultsThe withdrawal of rofecoxibA large simple clinical trial prototype for assessment of OTC drug effects using patient-reported dataSpontaneously reported fatal suspected adverse drug reactions: a 10-year survey from SwedenMarket withdrawal of new molecular entities approved in the United States from 1980 to 2009Anxiolytics, hypnotics, and antidepressants dispensed to adolescents in a French region in 2002The potential of the European network of congenital anomaly registers (EUROCAT) for drug safety surveillance: a descriptive studyU.S. physician knowledge of the FDA-approved indications and evidence base for commonly prescribed drugs: results of a national survey
P1433
Q23724881-F25AC8F0-7355-460E-AE79-B9B49BB836CAQ23922416-7E27C7D4-20EA-4D87-A479-5A0194FDB8FCQ23924129-25518000-63EB-409B-81E1-D8CF9BB78AE2Q24289525-F240A98D-946A-4429-8866-8B7059999D29Q24628874-F0B3C4CC-F40F-424A-A332-51C797FC07B9Q24653307-9C993880-C41E-4285-A092-EC4FA471E710Q26858860-D6605B05-0CEC-4784-A7C6-CEB19A2F9209Q26865575-B2918E87-43E8-4EFB-9E2C-CDE933540ED3Q26999267-FCC99AE6-1EC1-429F-BA4F-DC8C3A3B31D6Q27026648-70576D20-724F-46B1-A1F6-FAB55A373F64Q27026830-95278F4B-DC5B-4ACD-B283-8EB55C191593Q27331637-A37C8CE6-87AF-411A-9BDC-78009A8395E1Q28075754-FF377D8E-628F-4B8A-95B0-44DCB26F08DBQ28077862-2519125C-F14E-4CBC-890E-5E4F683193A9Q28165484-E2676490-A4BF-43F7-8B09-0D7A72DF1B30Q28165652-72382CF8-B54C-451E-95E0-7C0A5D58744AQ28171330-5D5C00D8-8260-4FFC-B386-A268DDCE7E75Q28173938-140C6EB3-BB8F-4A58-A04A-3C39678B602BQ28177261-9345151E-3F20-41B4-B488-D29A5BC7FE83Q28185419-FE439C7C-5264-4783-BBD6-7EDACF52CFEDQ28193491-17C2EC3C-9DE7-4DAE-90DE-FCEA9A98E02AQ28193635-B7E6678B-C948-42E6-8937-DB60E8D493FAQ28194350-978FF5CD-3FF2-4F27-BCE7-E9C3841A2B17Q28194361-7FFD218F-E704-4E59-9506-99FC0C079BC2Q28194561-C14AF239-50F1-4436-9C96-EB6CFEDF6D0DQ28199840-78862D00-91FD-4726-A722-09F5DA3A98A9Q28201145-CE8CFCD4-281F-4CFB-9BB0-F5A4870927A3Q28209939-A862CD80-2295-4AFE-98A4-52D24E45D3C1Q28212308-121203C6-12FB-4DF5-A0D7-D7B27BCE21A3Q28212637-A16A0F87-8F47-4246-8CCE-B0FBA4BA9C5EQ28212648-30F157E0-A399-4357-8766-C8CAC1114EC8Q28213626-7B031216-9A05-4D96-8E74-FE49211DC0F9Q28213637-609FB03F-BE1D-4495-8C40-74D3F83BD5D6Q28217969-C4A14E49-567C-4A69-8DD9-78E8DDC77419Q28218001-E31E23FC-F01B-4F20-92DD-BBD00A793439Q28218663-EE0E4078-569D-41A4-A839-35CBB5B9F840Q28237701-5D19EECE-ECE0-4326-8465-B747A1F01F2DQ28240168-E799221D-6D20-449B-A8EA-AB2BC3692293Q28244940-ABD0BD4D-C82B-4B7E-930D-58D2566DF509Q28255912-F7521E87-E8A7-48F2-9BDE-27ABB9DA2AD5
P1433
description
journal
@en
revista científica
@es
rivista scientifica
@it
wetenschappelijk tijdschrift van Wiley-Blackwell
@nl
wissenschaftliche Fachzeitschrift
@de
مجلة
@ar
name
Pharmacoepidemiology and Drug Safety
@ast
Pharmacoepidemiology and Drug Safety
@da
Pharmacoepidemiology and Drug Safety
@de
Pharmacoepidemiology and Drug Safety
@en
Pharmacoepidemiology and Drug Safety
@es
Pharmacoepidemiology and Drug Safety
@fi
Pharmacoepidemiology and Drug Safety
@fr
Pharmacoepidemiology and Drug Safety
@it
Pharmacoepidemiology and Drug Safety
@nb
Pharmacoepidemiology and Drug Safety
@nl
type
label
Pharmacoepidemiology and Drug Safety
@ast
Pharmacoepidemiology and Drug Safety
@da
Pharmacoepidemiology and Drug Safety
@de
Pharmacoepidemiology and Drug Safety
@en
Pharmacoepidemiology and Drug Safety
@es
Pharmacoepidemiology and Drug Safety
@fi
Pharmacoepidemiology and Drug Safety
@fr
Pharmacoepidemiology and Drug Safety
@it
Pharmacoepidemiology and Drug Safety
@nb
Pharmacoepidemiology and Drug Safety
@nl
prefLabel
Pharmacoepidemiology and Drug Safety
@ast
Pharmacoepidemiology and Drug Safety
@da
Pharmacoepidemiology and Drug Safety
@de
Pharmacoepidemiology and Drug Safety
@en
Pharmacoepidemiology and Drug Safety
@es
Pharmacoepidemiology and Drug Safety
@fi
Pharmacoepidemiology and Drug Safety
@fr
Pharmacoepidemiology and Drug Safety
@it
Pharmacoepidemiology and Drug Safety
@nb
Pharmacoepidemiology and Drug Safety
@nl
P31
P3181
P356
P1055
P1058
P1156
P123
P1277
P1476
Pharmacoepidemiology and Drug Safety
@en
P236
P3181
P356
10.1002/(ISSN)1099-1557
P571
1992-01-01T00:00:00Z